rs782523969
Positions:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 1P and 14B. PP2BP4_ModerateBP6_Very_StrongBS2
The NM_003334.4(UBA1):āc.388G>Cā(p.Val130Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000115 in 1,209,996 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 46 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.000098 ( 0 hom., 4 hem., cov: 23)
Exomes š: 0.00012 ( 0 hom. 42 hem. )
Consequence
UBA1
NM_003334.4 missense
NM_003334.4 missense
Scores
5
12
Clinical Significance
Conservation
PhyloP100: 4.80
Genes affected
UBA1 (HGNC:12469): (ubiquitin like modifier activating enzyme 1) The protein encoded by this gene catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation. This gene complements an X-linked mouse temperature-sensitive defect in DNA synthesis, and thus may function in DNA repair. It is part of a gene cluster on chromosome Xp11.23. Alternatively spliced transcript variants that encode the same protein have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), UBA1. . Gene score misZ 3.4752 (greater than the threshold 3.09). GenCC has associacion of gene with infantile-onset X-linked spinal muscular atrophy, inflammatory disease.
BP4
Computational evidence support a benign effect (MetaRNN=0.257231).
BP6
Variant X-47199522-G-C is Benign according to our data. Variant chrX-47199522-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 533621.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 4 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UBA1 | NM_003334.4 | c.388G>C | p.Val130Leu | missense_variant | 5/26 | ENST00000335972.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UBA1 | ENST00000335972.11 | c.388G>C | p.Val130Leu | missense_variant | 5/26 | 1 | NM_003334.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000984 AC: 11AN: 111787Hom.: 0 Cov.: 23 AF XY: 0.000118 AC XY: 4AN XY: 33955
GnomAD3 genomes
AF:
AC:
11
AN:
111787
Hom.:
Cov.:
23
AF XY:
AC XY:
4
AN XY:
33955
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000327 AC: 6AN: 183507Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67935
GnomAD3 exomes
AF:
AC:
6
AN:
183507
Hom.:
AF XY:
AC XY:
0
AN XY:
67935
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000117 AC: 128AN: 1098209Hom.: 0 Cov.: 33 AF XY: 0.000116 AC XY: 42AN XY: 363563
GnomAD4 exome
AF:
AC:
128
AN:
1098209
Hom.:
Cov.:
33
AF XY:
AC XY:
42
AN XY:
363563
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000984 AC: 11AN: 111787Hom.: 0 Cov.: 23 AF XY: 0.000118 AC XY: 4AN XY: 33955
GnomAD4 genome
AF:
AC:
11
AN:
111787
Hom.:
Cov.:
23
AF XY:
AC XY:
4
AN XY:
33955
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Infantile-onset X-linked spinal muscular atrophy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 24, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;T;T;T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;.;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.;.;.;L;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;N;N;N
REVEL
Benign
Sift
Benign
T;D;D;T;D;T;D
Sift4G
Benign
T;T;T;T;D;T;T
Polyphen
B;.;.;.;.;B;.
Vest4
MutPred
Gain of ubiquitination at K125 (P = 0.1204);Gain of ubiquitination at K125 (P = 0.1204);.;.;.;Gain of ubiquitination at K125 (P = 0.1204);.;
MVP
MPC
0.48
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at